clofibric acid has been researched along with Melanoma in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dellavalle, RP | 1 |
Drake, A | 1 |
Graber, M | 1 |
Heilig, LF | 1 |
Hester, EJ | 1 |
Johnson, KR | 1 |
McNealy, K | 1 |
Schilling, L | 1 |
1 review available for clofibric acid and Melanoma
Article | Year |
---|---|
Statins and fibrates for preventing melanoma.
Topics: Anticholesteremic Agents; Clofibric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Me | 2005 |